This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James T. Robertson, MD

Arch Neurol. 1994;51(5):455-456.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CAROTID ENDARTERECTOMY for carotid stenosis of 70% or more is the treatment of choice to prevent stroke in any brain vascular territory as well as ipsilaterally in patients presenting with symptoms of transient monocular blindness, transient cerebral ischemia, and small disabling stroke providing the surgical stroke morbidity is 3% or less and the stroke mortality is 1% or less. To date, this scenario is the only scientifically proven indication for the operation. Under these circumstances, there is an absolute risk reduction of stroke in favor of surgery of 17% and a relative risk reduction of 65% when compared with the best medical therapy.

Two major prospective randomized studies for symptomatic and asymptomatic carotid stenosis are in progress. The North American Symptomatic Carotid Endarterectomy Trial continues to accrue and analyze the surgical results in patients presenting with transient cerebral ischemic attacks and small nondisabling stroke with ipsilateral carotid stenosis of 30% . . . [Full Text PDF of this Article]

Author Affiliations
Memphis, Tenn

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?